Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

Authors A Anzueto, I Leimer, S Kesten

Published 24 June 2009 Volume 2009:4 Pages 245—251

DOI https://doi.org/10.2147/COPD.S4862

Review by Single-blind

Peer reviewer comments 4

A Anzueto1, I Leimer2, S Kesten3

1The University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System, Audie L Murphy Division, San Antonio, Texas, USA; 2Boehringer Ingelheim, Ridgefield, Connecticut, USA; 3Boehringer Ingelheim GmbH, Ingelheim, Germany

Background: COPD exacerbations are responsible for the morbidity and mortality of this disease. The relationship between exacerbations and patient-related clinical outcomes is not clearly understood.

Methods: A retrospective analysis of two 1-year, placebo-controlled clinical trials with tiotropium 18 µg daily was conducted to examine relationships between exacerbations and other clinical outcomes. The relationship between FEV1, St. George’s Respiratory Questionnaire (SGRQ), and the transition dyspnea index (TDI) were examined based on the frequency of exacerbations (0, 1, 2, >2).

Results: 921 patients participated in the trials (mean age 65 years, mean FEV1 = 1.02 L (39% predicted). The percent change from baseline in FEV1 in the tiotropium group was +12.6%, +12.0%, +2.1% and +8.9%; and in the placebo group was −3.4%, −3.4%, −5.7% and −6.7% for exacerbation frequencies of 0, 1, 2, >2, respectively. Compared with baseline, the largest improvement in SGRQ occurred in patients with no exacerbations. In the placebo group, there was a significant association between an increased frequency of exacerbations and worsening SGRQ scores. A reduction in exacerbation rates of 4.4% to 42.0% such as that shown in this study cohort was associated with meaningful changes in questionnaire based instruments.

Conclusions: In the placebo-treated patients increased frequency of exacerbations was associated with larger decrements in FEV1, TDI, and SGRQ. A reduction in the frequency of exacerbations is associated with changes that are considered meaningful in these clinical outcomes.

Keywords: exacerbations, chronic obstructive pulmonary disease, FEV1, dyspnea, quality of life

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Tiotropium HandiHaler® in the treatment of COPD: A safety review

Steven Kesten, Bart Celli, Marc Decramer, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:397-409

Published Date: 28 October 2009

Readers of this article also read:

COPD exacerbation frequency and its association with health care resource utilization and costs

Dhamane AD, Moretz C, Zhou Y, Burslem K, Saverno K, Jain G, Renda A, Kaila S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2609-2618

Published Date: 3 December 2015

Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD

Kurashima K, Takaku Y, Hoshi T, Kanauchi T, Nakamoto K, Takayanagi N, Yanagisawa T, Sugita Y, Kawabata Y

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1027-1033

Published Date: 2 June 2015

Chronic obstructive pulmonary disease exacerbation frequency and severity

Stafyla E, Kerenidi T, Gourgoulianis KI

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:533-535

Published Date: 6 November 2013

Quantitative assessment of walking time and postural change in patients with COPD using a new triaxial accelerometer system

Kawagoshi A, Kiyokawa N, Sugawara K, Takahashi H, Sakata S, Miura S, Sawamura S, Satake M, Shioya T

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:397-404

Published Date: 2 September 2013

Exacerbation frequency and course of COPD

Halpin DMG, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:653-661

Published Date: 21 September 2012

Association between lung function and exacerbation frequency in patients with COPD

Martine Hoogendoorn, Talitha L Feenstra, Rudolf T Hoogenveen, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:435-444

Published Date: 9 December 2010